R Todd Ogden Selected Research

5-HT1A Serotonin Receptor

12/2022	Brain 5-HT1A Receptor PET Binding, Cortisol Responses to Stress, and the Familial Transmission of Suicidal Behavior.
1/2022	Serotonin 1A Receptor Binding of [11C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response.
1/2019	Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding.
7/2018	In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
2/2015	Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.
7/2014	Genetic variation in brain-derived neurotrophic factor val66met allele is associated with altered serotonin-1A receptor binding in human brain.
11/2013	Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.
11/2013	Higher pretreatment 5-HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: a naturalistic treatment pilot PET study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Todd Ogden Research Topics

Disease

22	Major Depressive Disorder (Major Depressive Disorders) 08/2022 - 01/2006
6	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 02/2007
1	Mood Disorders (Mood Disorder) 12/2022
1	Ascites 01/2021
1	Parkinson Disease 16 01/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Cognitive Dysfunction 01/2017
1	Dementia (Dementias) 01/2017
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 08/2015
1	Stroke (Strokes) 01/2015
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2013
1	Brain Diseases (Brain Disorder) 03/2013
1	Mental Disorders (Mental Disorder) 07/2009
1	Alzheimer Disease (Alzheimer's Disease) 04/2008
1	Schizophrenia (Dementia Praecox) 04/2008

Drug/Important Bio-Agent (IBA)

11	Serotonin (5 Hydroxytryptamine)IBA 08/2022 - 01/2006
9	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2022 - 01/2006
8	5-HT1A Serotonin ReceptorIBA 12/2022 - 11/2013
6	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2019 - 08/2009
4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 10/2018 - 03/2013
3	AutoreceptorsIBA 01/2018 - 03/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2022 - 01/2019
2	LigandsIBA 01/2021 - 07/2014
2	Ketamine FDA LinkGeneric 01/2020 - 08/2015
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 02/2007 - 01/2006
1	LipopolysaccharidesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2021
1	LithiumIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2019
1	Glutamic Acid (Glutamate)FDA Link 08/2015
1	gamma-Aminobutyric Acid (GABA)IBA 08/2015
1	Glutamine (L-Glutamine)FDA Link 08/2015
1	CarbonIBA 02/2015
1	Escitalopram FDA Link 11/2013
1	Serotonin 5-HT1 Receptor AntagonistsIBA 03/2013
1	Biological ProductsIBA 07/2009
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 10/2008
1	McN 5652IBA 01/2006

Therapy/Procedure

1	Transcranial Magnetic Stimulation 01/2015